ArticleCurrent developments in nutrition2025
Principal Components Analysis of Spot Urine Caffeine and Caffeine Metabolites Identifies Promising Exposure Biomarkers of Caffeine and Theobromine Intake in a Cross-Sectional Survey of the United States Population (National Health and Nutrition Examination Survey 2009-2014).
Article in Current developments in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spot urine concentrations of caffeine and certain caffeine metabolites correlate well with 24-h caffeine intake and have potential use as caffeine exposure biomarkers. However, a high degree of intercorrelation exists among these urine compounds, and their correlations with intake are very similar, making the selection of a single intake biomarker challenging based on bivariate analyses alone. Objectives: To use principal components (PCs) analysis (PCA) as a dimensionality reduction tool to identify underlying correlation structures in the relationship of caffeine intake with spot urine caffeine and caffeine metabolite concentrations. Methods: We performed weighted bivariate analyses and a weighted PCA of spot urine concentrations of caffeine and 14 caffeine metabolites, and 24-h intakes of caffeine (foods, beverages, and supplements) and theobromine (foods and beverages) from 7732 participants ≥6 y in the National Health and Nutrition Examination Survey (NHANES) 2009-2014. Results: Bivariate analyses revealed intercorrelation patterns that effectively divided the urine analytes into 2 groups based on their association with either caffeine or theobromine intake. PCA yielded 2 components (PC1 and PC2) that accounted for 83.0% of the total variance. PC1 (70.9%) showed a positive correlation with all original variables and approximated a weighted sum related to the urine analyte concentrations in the original data. PC2 (12.1%) yielded 2 clusters of correlated variables resembling a weighted contrast of the caffeine and theobromine intake associations observed in the original data. Urine 1-methylxanthine showed the strongest PCA correlation with caffeine intake, followed by 5-acetylamino-6-amino-3-methyluracil, 1-methyluric acid, and 1,7-dimethyluric acid. Urine theobromine and its downstream metabolites showed PCA correlation primarily with theobromine intake, though correlation with caffeine intake was also evident. Conclusions: With PCA, we were able to identify an underlying correlation structure in the NHANES 2009-2014 data that revealed promising urine exposure biomarkers of caffeine and theobromine intake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.